
Petri Dish: Cancer biotech cuts staff; Lantheus sells business unit
In recent days, a Cambridge biotech laid off more than half of its workers, a radiopharmaceutical company sold part of its business, a Burlington biotech got new investment and a George Church-founded xenotransplantation biotech brought on a medical chief.